Fennec Pharmaceuticals (FENC) FCF Margin (2020 - 2025)
Fennec Pharmaceuticals (FENC) posted FCF Margin of 43.28% for Q4 2025, down 461.21% on a QoQ basis from 11.98% in Q3 2025, and down 2468.0% year-over-year from 1.83% in Q4 2024.
Fennec Pharmaceuticals (FENC) FCF Margin (2020 - 2025) Analysis & Trends
Fennec Pharmaceuticals' FCF Margin history runs 4 years deep, the most recent figure standing at 43.28% for Q4 2025.
- Quarterly FCF Margin fell 2468.0% year-over-year to 43.28% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 27.94% (down 8103.0% YoY) and the FY2025 annual result came in at 34.19%, down 9095.0% from the prior year.
- FCF Margin was 43.28% for Q4 2025 at Fennec Pharmaceuticals, down from 11.98% in the prior quarter.
- Across five years, FCF Margin topped out at 147.01% in Q1 2024 and bottomed at 332.56% in Q1 2023.
- A 3-year average of 56.75% and a median of 42.82% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin jumped 47957 bps — and 2025, when it slumped 19635 bps.
- Fennec Pharmaceuticals' FCF Margin stood at 49.92% in 2023, then surged by 63 bps to 18.6% in 2024, then tumbled by 133 bps to 43.28% in 2025.
- Business Quant data shows FENC's FCF Margin at 43.28% in Q4 2025, 11.98% in Q3 2025, and 38.19% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -43.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43.28% |
| Sep 30, 2025 | 11.98% |
| Jun 30, 2025 | -38.19% |
| Mar 31, 2025 | -49.34% |
| Dec 31, 2024 | -18.60% |
| Sep 30, 2024 | -31.63% |
| Jun 30, 2024 | -115.49% |
| Mar 31, 2024 | 147.01% |
| Dec 31, 2023 | -49.92% |
| Sep 30, 2023 | -42.36% |
| Jun 30, 2023 | -118.68% |
| Mar 31, 2023 | -332.56% |
| Dec 31, 2020 | -1,642.00% |